Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Compugen Ltd (NQ: CGEN)
3.400 USD  +0.010 (+0.29%)
Streaming Delayed Price  /  Updated: 11:12 AM EDT, Jun 17, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 4,106
Open 3.410
Bid (Size) 3.400 (5)
Ask (Size) 3.430 (33)
Prev. Close 3.390
Today's Range 3.370 - 3.430
52wk Range 2.000 - 4.310
Shares Outstanding 45,822,807
Dividend Yield N/A
Performance
YTD
+44.68%
+44.68%
1 Month
-1.73%
-1.73%
3 Month
-10.53%
-10.53%
6 Month
+19.30%
+19.30%
1 Year
-9.33%
-9.33%
Top News
More News
Compugen Presents Update on COM701 Phase 1 Trial at the 2019 ASCO Annual Meeting
Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, today announced that its ongoing Phase 1 clinical trial evaluating COM701, a... Read More
from PR Newswire
Compugen to Present at the Jefferies 2019 Healthcare Conference
Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today announced that Anat Cohen-Dayag, PhD, President and CEO,... Read More
from PR Newswire
More News
Read More
Compugen Reports First Quarter 2019 Results
from PR Newswire
Compugen Doses First Patient in COM701/Opdivo® (Nivolumab) Combination Arm of Phase 1 Study in Patients With Advanced Solid Tumors
from PR Newswire
Compugen First Quarter 2019 Conference Call Scheduled for Monday, May 20, 2019 at 8:30 AM ET
from PR Newswire
Report: Exploring Fundamental Drivers Behind Masco, Ascena Retail Group, Minerva Neurosciences, Compugen, Mountain Province Diamonds, and Luna Innovations — New Horizons, Emerging Trends, and Upcoming
from GlobeNewswire News Releases
Compugen Presents Update on COM701 Phase 1 Trial at the 2019 AACR Annual Meeting
from PR Newswire
Chinese Regulatory Authority [NMPA] Approves IND Application of Oramed's Oral Insulin Capsules
from PR Newswire
Compugen Announces Purchase of Company Shares by its Board of Directors and Members of Management
from PR Newswire
Compugen Announces Issuance of Two U.S. Composition of Matter Patents for COM701, Its Lead Immuno-Oncology Product Candidate
from PR Newswire
Compugen to Present at the Cowen and Company 39th Annual Health Care Conference
from PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.